buspirone has been researched along with Acute Symptom Flare in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Individuals with PD and clinically significant anxiety were randomized 4:1 to flexible dosage buspirone or placebo for 12 weeks." | 9.34 | A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability. ( Auinger, P; Gil-Díaz, MC; Iourinets, J; Richard, IH; Schneider, RB; Tarolli, CG, 2020) |
| "Individuals with PD and clinically significant anxiety were randomized 4:1 to flexible dosage buspirone or placebo for 12 weeks." | 5.34 | A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability. ( Auinger, P; Gil-Díaz, MC; Iourinets, J; Richard, IH; Schneider, RB; Tarolli, CG, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, RB | 1 |
| Auinger, P | 1 |
| Tarolli, CG | 1 |
| Iourinets, J | 1 |
| Gil-Díaz, MC | 1 |
| Richard, IH | 1 |
1 trial available for buspirone and Acute Symptom Flare
| Article | Year |
|---|---|
A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Drug Tapering; Female; Humans; | 2020 |